| Dr David Jeffrey Eisenstein, MD | |
|
4500 Memorial Dr, Dept Pathology, Belleville, IL 62226-5360 | |
| (618) 233-7750 | |
| (314) 747-1710 |
| Full Name | Dr David Jeffrey Eisenstein |
|---|---|
| Gender | Male |
| Speciality | Pathology |
| Experience | 35 Years |
| Location | 4500 Memorial Dr, Belleville, Illinois |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1598757031 | NPI | - | NPPES |
| 200016959 | Medicaid | MO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0101X | Pathology - Anatomic Pathology | 036136527 (Illinois) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Missouri Baptist Medical Center | Town and country, MO | Hospital |
| Barnes-jewish St Peters Hospital | Saint peters, MO | Hospital |
| Progress West Hospital | O fallon, MO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Parkway Pathology Group Inc | 5496728818 | 8 |
News Archive
A new study that followed more than 2,600 men and women for 16 years found that consuming less sodium wasn't associated with lower blood pressure. The new findings call into question the sodium limits recommended by the current Dietary Guidelines for Americans.
AVEO Pharmaceuticals, Inc. and Astellas Pharma Inc. today announced that tivozanib demonstrated superiority over sorafenib in the primary endpoint of progression-free survival (PFS) in TIVO-1, a global, randomized Phase 3 clinical trial evaluating the efficacy and safety of investigational drug tivozanib compared to sorafenib in 517 patients with advanced renal cell carcinoma.
LifeCycle Pharma and Sciele Pharma announce FDA approval of fenofibrate in 120 mg. and 40 mg. dosage strengths. Sciele Pharma expects U.S. market launch by the end of 2007.
New proposals to reduce the risk of anaesthetic tubing becoming blocked during operations, were published today. Following 11 similar NHS cases where tubing had become blocked, the Chief Medical Officer, Sir Liam Donaldson set up an Expert Group in July 2002 to look into the issue.
According to a recent Finnish study, higher levels of moderate and vigorous physical activity can curb arterial stiffening already in childhood. However, sedentary time or aerobic fitness were not linked to arterial health.
› Verified 6 days ago
| Entity Name | Parkway Pathology Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1245206960 PECOS PAC ID: 5496728818 Enrollment ID: O20040814000088 |
News Archive
A new study that followed more than 2,600 men and women for 16 years found that consuming less sodium wasn't associated with lower blood pressure. The new findings call into question the sodium limits recommended by the current Dietary Guidelines for Americans.
AVEO Pharmaceuticals, Inc. and Astellas Pharma Inc. today announced that tivozanib demonstrated superiority over sorafenib in the primary endpoint of progression-free survival (PFS) in TIVO-1, a global, randomized Phase 3 clinical trial evaluating the efficacy and safety of investigational drug tivozanib compared to sorafenib in 517 patients with advanced renal cell carcinoma.
LifeCycle Pharma and Sciele Pharma announce FDA approval of fenofibrate in 120 mg. and 40 mg. dosage strengths. Sciele Pharma expects U.S. market launch by the end of 2007.
New proposals to reduce the risk of anaesthetic tubing becoming blocked during operations, were published today. Following 11 similar NHS cases where tubing had become blocked, the Chief Medical Officer, Sir Liam Donaldson set up an Expert Group in July 2002 to look into the issue.
According to a recent Finnish study, higher levels of moderate and vigorous physical activity can curb arterial stiffening already in childhood. However, sedentary time or aerobic fitness were not linked to arterial health.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr David Jeffrey Eisenstein, MD 660 S Euclid Ave, Cb 8118, Saint Louis, MO 63110-1010 Ph: (314) 362-5641 | Dr David Jeffrey Eisenstein, MD 4500 Memorial Dr, Dept Pathology, Belleville, IL 62226-5360 Ph: (618) 233-7750 |
News Archive
A new study that followed more than 2,600 men and women for 16 years found that consuming less sodium wasn't associated with lower blood pressure. The new findings call into question the sodium limits recommended by the current Dietary Guidelines for Americans.
AVEO Pharmaceuticals, Inc. and Astellas Pharma Inc. today announced that tivozanib demonstrated superiority over sorafenib in the primary endpoint of progression-free survival (PFS) in TIVO-1, a global, randomized Phase 3 clinical trial evaluating the efficacy and safety of investigational drug tivozanib compared to sorafenib in 517 patients with advanced renal cell carcinoma.
LifeCycle Pharma and Sciele Pharma announce FDA approval of fenofibrate in 120 mg. and 40 mg. dosage strengths. Sciele Pharma expects U.S. market launch by the end of 2007.
New proposals to reduce the risk of anaesthetic tubing becoming blocked during operations, were published today. Following 11 similar NHS cases where tubing had become blocked, the Chief Medical Officer, Sir Liam Donaldson set up an Expert Group in July 2002 to look into the issue.
According to a recent Finnish study, higher levels of moderate and vigorous physical activity can curb arterial stiffening already in childhood. However, sedentary time or aerobic fitness were not linked to arterial health.
› Verified 6 days ago
Dr. Ram Sai Bala, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 211 S 3rd St, Dept. Of Pathology, Belleville, IL 62220 Phone: 618-234-2120 Fax: 618-222-4630 | |
Dr. Vidya Deshpande, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 45 Sheffield Drive, Belleville, IL 62243 Phone: 618-235-0777 Fax: 618-233-8335 | |
Dr. Olivia Jo Ludwig, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 211 S 3rd St, Belleville, IL 62220 Phone: 618-234-2120 Fax: 618-222-4630 | |
Christopher Murphy, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 211 S 3rd St, Belleville, IL 62220 Phone: 618-234-2120 Fax: 618-222-4630 | |
Dolph D Haege, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 211 S 3rd St, Belleville, IL 62220 Phone: 618-234-2120 Fax: 618-222-4630 | |
Stephen Michael Olson, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 211 S 3rd St, Belleville, IL 62220 Phone: 618-234-2120 |